Back
Arcellx Vs. Aligos Therapeutics Industry Stock Comparison
Sell
16
ACLX
Arcellx
Last Price:
$64.57
Seasonality Move:
-0.35%
Sell
29
ALGS
Aligos Therapeutics
Last Price:
$32.55
Seasonality Move:
-18.25%
Sell
29
Aligos Therapeutics (ALGS)
is a Sell
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $30.05. The Score for ALGS is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
ALGS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $30.05The current trend is moderately bearish and ALGS is experiencing selling pressure, which indicates risk of future bearish movement.
ACLX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.29 | Sell |
Relative Strength Index (14 RSI): | 27.2 | Sell |
Chaikin Money Flow: | -625099 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (72.51 - 83.21) | Sell |
Bollinger Bands (100): | (73.42 - 91.06) | Sell |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.14 | Buy |
Relative Strength Index (14 RSI): | 41.89 | Sell |
Chaikin Money Flow: | -263729 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (31.95 - 41.43) | Sell |
Bollinger Bands (100): | (7.22 - 30.48) | Buy |
ACLX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 72.91 | Sell |
20-day SMA: | 76.32 | Sell |
50-day SMA: | 84.61 | Sell |
200-day SMA: | 69.34 | Sell |
8-day EMA: | 71.25 | Sell |
20-day EMA: | 75.92 | Sell |
50-day EMA: | 80.38 | Sell |
200-day EMA: | 72.24 | Sell |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.28 | Sell |
20-day SMA: | 38.13 | Sell |
50-day SMA: | 27.37 | Buy |
200-day SMA: | 17.35 | Buy |
8-day EMA: | 36.3 | Sell |
20-day EMA: | 36.12 | Sell |
50-day EMA: | 29.44 | Buy |
200-day EMA: | 20.26 | Buy |
Arcellx Earnings Growth & ACLX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.73 per share, and a decrease next year of $0.69 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.65 per share, and a decrease next year of $0.14 per share.
Arcellx Technical Analysis
Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |